Rituximab in the Treatment of Patients With Bullous Pemphigoid
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study will determine the safety of treatment of bullous pemphigoid in patients resistant
to therapy with systemic corticosteroids, with rituximab plus systemic corticosteroids.